Rain Therapeutics Inc. (RAIN) Event Aug. 04, 2022, 05:01 UTC Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma Full text
There are no comments here yet...